APA (7th ed.) Citation

Hung, N. A., Costa, F. G., Hung, C., & Rosenberg, M. E. (2020). Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design). Clinical pharmacology in drug development, 9(5), 610-620. https://doi.org/10.1002/cpdd.813

Chicago Style (17th ed.) Citation

Hung, Noelyn Anne, Fernando Guillermo Costa, Cheung‐Tak Hung, and Mónica Esther Rosenberg. "Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 Mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design)." Clinical Pharmacology in Drug Development 9, no. 5 (2020): 610-620. https://doi.org/10.1002/cpdd.813.

MLA (9th ed.) Citation

Hung, Noelyn Anne, et al. "Bioequivalence Study of 2 Capsule Formulations of Fingolimod 0.5 Mg Assessing Both Parent Drug and Active Metabolite in New Zealand Healthy Subjects (Truncated Design)." Clinical Pharmacology in Drug Development, vol. 9, no. 5, 2020, pp. 610-620, https://doi.org/10.1002/cpdd.813.